P23: RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS. A MULTICENTER RETROSPECTIVE ANALYSIS OF ELIGIBILITY CRITERIA FOR CAR-T CELL THERAPY.
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-04-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000829664.02846.2b |
| _version_ | 1797283002013712384 |
|---|---|
| author | F Fazio A Di Rocco T Za V Tomarchio A Rago A Piciocchi T Caravita di Toritto O Annibali V De Stefano R Foà M Martelli MT Petrucci |
| author_facet | F Fazio A Di Rocco T Za V Tomarchio A Rago A Piciocchi T Caravita di Toritto O Annibali V De Stefano R Foà M Martelli MT Petrucci |
| author_sort | F Fazio |
| collection | DOAJ |
| first_indexed | 2024-03-07T17:21:38Z |
| format | Article |
| id | doaj.art-e9200d7e82ba487a825e59b7717125e1 |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T17:21:38Z |
| publishDate | 2022-04-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-e9200d7e82ba487a825e59b7717125e12024-03-02T19:48:45ZengWileyHemaSphere2572-92412022-04-016232410.1097/01.HS9.0000829664.02846.2b202204002-00046P23: RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS. A MULTICENTER RETROSPECTIVE ANALYSIS OF ELIGIBILITY CRITERIA FOR CAR-T CELL THERAPY.F Fazio0A Di Rocco1T Za2V Tomarchio3A Rago4A Piciocchi5T Caravita di Toritto6O Annibali7V De Stefano8R Foà9M Martelli10MT Petrucci111 Hematology, Department of Translational and Precision Medicine, Azienda Ospedaliera Policlinico Umberto I, Sapienza University of Rome1 Hematology, Department of Translational and Precision Medicine, Azienda Ospedaliera Policlinico Umberto I, Sapienza University of Rome2 Section of Hematology, Department of Radiological and Hematological Sciences, Catholic University, Fondazione Policlinico A. Gemelli, IRCCS; Rome3 Unit of Hematology, Stem Cell Transplantation, University Campus Bio Medico, Rome4 UOSD Ematologia ASL Roma, Rome5 Italian Group For Adult Hematologic Diseases (GIMEMA), Rome4 UOSD Ematologia ASL Roma, Rome2 Section of Hematology, Department of Radiological and Hematological Sciences, Catholic University, Fondazione Policlinico A. Gemelli, IRCCS; Rome2 Section of Hematology, Department of Radiological and Hematological Sciences, Catholic University, Fondazione Policlinico A. Gemelli, IRCCS; Rome1 Hematology, Department of Translational and Precision Medicine, Azienda Ospedaliera Policlinico Umberto I, Sapienza University of Rome1 Hematology, Department of Translational and Precision Medicine, Azienda Ospedaliera Policlinico Umberto I, Sapienza University of Rome1 Hematology, Department of Translational and Precision Medicine, Azienda Ospedaliera Policlinico Umberto I, Sapienza University of Romehttp://journals.lww.com/10.1097/01.HS9.0000829664.02846.2b |
| spellingShingle | F Fazio A Di Rocco T Za V Tomarchio A Rago A Piciocchi T Caravita di Toritto O Annibali V De Stefano R Foà M Martelli MT Petrucci P23: RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS. A MULTICENTER RETROSPECTIVE ANALYSIS OF ELIGIBILITY CRITERIA FOR CAR-T CELL THERAPY. HemaSphere |
| title | P23: RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS. A MULTICENTER RETROSPECTIVE ANALYSIS OF ELIGIBILITY CRITERIA FOR CAR-T CELL THERAPY. |
| title_full | P23: RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS. A MULTICENTER RETROSPECTIVE ANALYSIS OF ELIGIBILITY CRITERIA FOR CAR-T CELL THERAPY. |
| title_fullStr | P23: RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS. A MULTICENTER RETROSPECTIVE ANALYSIS OF ELIGIBILITY CRITERIA FOR CAR-T CELL THERAPY. |
| title_full_unstemmed | P23: RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS. A MULTICENTER RETROSPECTIVE ANALYSIS OF ELIGIBILITY CRITERIA FOR CAR-T CELL THERAPY. |
| title_short | P23: RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS. A MULTICENTER RETROSPECTIVE ANALYSIS OF ELIGIBILITY CRITERIA FOR CAR-T CELL THERAPY. |
| title_sort | p23 relapsed refractory multiple myeloma patients a multicenter retrospective analysis of eligibility criteria for car t cell therapy |
| url | http://journals.lww.com/10.1097/01.HS9.0000829664.02846.2b |
| work_keys_str_mv | AT ffazio p23relapsedrefractorymultiplemyelomapatientsamulticenterretrospectiveanalysisofeligibilitycriteriaforcartcelltherapy AT adirocco p23relapsedrefractorymultiplemyelomapatientsamulticenterretrospectiveanalysisofeligibilitycriteriaforcartcelltherapy AT tza p23relapsedrefractorymultiplemyelomapatientsamulticenterretrospectiveanalysisofeligibilitycriteriaforcartcelltherapy AT vtomarchio p23relapsedrefractorymultiplemyelomapatientsamulticenterretrospectiveanalysisofeligibilitycriteriaforcartcelltherapy AT arago p23relapsedrefractorymultiplemyelomapatientsamulticenterretrospectiveanalysisofeligibilitycriteriaforcartcelltherapy AT apiciocchi p23relapsedrefractorymultiplemyelomapatientsamulticenterretrospectiveanalysisofeligibilitycriteriaforcartcelltherapy AT tcaravitaditoritto p23relapsedrefractorymultiplemyelomapatientsamulticenterretrospectiveanalysisofeligibilitycriteriaforcartcelltherapy AT oannibali p23relapsedrefractorymultiplemyelomapatientsamulticenterretrospectiveanalysisofeligibilitycriteriaforcartcelltherapy AT vdestefano p23relapsedrefractorymultiplemyelomapatientsamulticenterretrospectiveanalysisofeligibilitycriteriaforcartcelltherapy AT rfoa p23relapsedrefractorymultiplemyelomapatientsamulticenterretrospectiveanalysisofeligibilitycriteriaforcartcelltherapy AT mmartelli p23relapsedrefractorymultiplemyelomapatientsamulticenterretrospectiveanalysisofeligibilitycriteriaforcartcelltherapy AT mtpetrucci p23relapsedrefractorymultiplemyelomapatientsamulticenterretrospectiveanalysisofeligibilitycriteriaforcartcelltherapy |